(Q41092073)

26 September 2017

Apo E allele frequencies in younger (age 42-50) vs older (age 65-90) women (English)

1 reference

26 September 2017

5

Kuller LH

1 reference

26 September 2017

Cauley JA

1

1 reference

26 September 2017

Eichner JE

series ordinal

2

1 reference

26 September 2017

Kamboh MI

series ordinal

3

1 reference

26 September 2017

Ferrell RE

series ordinal

4

1 reference

26 September 2017

1 January 1993

1 reference

26 September 2017

1 reference

26 September 2017

10

1 reference

26 September 2017

1

1 reference

26 September 2017

27-34

1 reference

Appendicular bone density and age predict hip fracture in women. The Study of Osteoporotic Fractures Research Group

26 September 2017

1 reference

https://api.crossref.org/works/10.1002%2FGEPI.1370100104

Apolipoprotein E polymorphism in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGEPI.1370100104

Apolipoprotein E polymorphism and plasma lipid, lipoprotein, and apolipoprotein levels in Italian children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGEPI.1370100104

The use of measured genotype information in the analysis of quantitative phenotypes in man. II. The role of the apolipoprotein E polymorphism in determining levels, variability, and covariability of cholesterol, betalipoprotein, and triglycerides in

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGEPI.1370100104

7 January 2021

NIH conference. Type III hyperlipoproteinemia: diagnosis, molecular defects, pathology, and treatment

1 reference

https://api.crossref.org/works/10.1002%2FGEPI.1370100104

7 January 2021

Polymorphism at the apoprotein-E locus in relation to risk of coronary disease

1 reference

https://api.crossref.org/works/10.1002%2FGEPI.1370100104

7 January 2021

Apolipoprotein E polymorphism and atherosclerosis

1 reference

https://api.crossref.org/works/10.1002%2FGEPI.1370100104

7 January 2021

Phenotypic effects of apolipoprotein structural variation on lipid profiles. IV. Apolipoprotein polymorphisms in a small group of black women from the healthy women study

1 reference

https://api.crossref.org/works/10.1002%2FGEPI.1370100104

7 January 2021

Phenotypic effects of apolipoprotein structural variation on lipid profiles. III. Contribution of apolipoprotein E phenotype to prediction of total cholesterol, apolipoprotein B, and low density lipoprotein cholesterol in the healthy women study

1 reference

https://api.crossref.org/works/10.1002%2FGEPI.1370100104

7 January 2021

Effects of polymorphisms in apolipoproteins E, A-IV, and H on quantitative traits related to risk for cardiovascular disease

1 reference

https://api.crossref.org/works/10.1002%2FGEPI.1370100104

7 January 2021

Lipoprotein receptors and cholesterol homeostasis

1 reference

https://api.crossref.org/works/10.1002%2FGEPI.1370100104

7 January 2021

Menopause and risk factors for coronary heart disease

1 reference

https://api.crossref.org/works/10.1002%2FGEPI.1370100104

7 January 2021

Apolipoprotein E phenotypes in patients with myocardial infarction

1 reference

https://api.crossref.org/works/10.1002%2FGEPI.1370100104

7 January 2021

Identifiers

DOI

10.1002/GEPI.1370100104

1 reference

26 September 2017

1 reference